Victory Capital Management Inc Caladrius Biosciences, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.66 - $2.38 $2,421 - $3,472	-1,459 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.21 - $3.47 $39 - $114	-33 Reduced 2.21%	1,459 $3,000
Q4 2019 Feb 04, 2020	SELL	$2.02 - $2.85 $288 - $407	-143 Reduced 8.75%	1,492 $4,000
Q3 2019 Nov 12, 2019	BUY	$2.22 - $2.99 $3,629 - $4,888	1,635 New	1,635 $4,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.